Compare HOG & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOG | PRGO |
|---|---|---|
| Founded | 1903 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | N/A | 1991 |
| Metric | HOG | PRGO |
|---|---|---|
| Price | $20.60 | $14.91 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $27.43 | $20.33 |
| AVG Volume (30 Days) | 2.6M | ★ 2.6M |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | 3.50% | ★ 7.78% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.04 | N/A |
| Revenue | ★ $4,664,627,000.00 | $4,281,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.04 | N/A |
| P/E Ratio | $5.08 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.90 | $12.17 |
| 52 Week High | $31.25 | $30.93 |
| Indicator | HOG | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 44.79 | 53.90 |
| Support Level | $19.90 | $14.66 |
| Resistance Level | $21.46 | $15.38 |
| Average True Range (ATR) | 0.55 | 0.49 |
| MACD | 0.09 | 0.06 |
| Stochastic Oscillator | 57.74 | 60.19 |
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 37% of the heavyweight domestic market in 2024.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.